Otrexup Injection, Solution
Pricing Report NDC 54436-015-04

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Otrexup (NDC 54436-015-04) is $484.20973 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 01, 2025.

As a a human prescription drug provided by Antares Pharma, Inc., this medication is distributed in a 4 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE (54436-015-02) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$484.20973
Per ML

Effective Date
Apr 01, 2025
Data Status
As of Apr 15, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
4 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE (54436-015-02)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2019, the NADAC wholesale price for (NDC ) has moved within a range of $394.13375 to $484.20973 per ML. Over this 5 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$394.1338 - $484.2097
Market Volatility
22.85% Variance
Latest Trend
2.90%
Date Unit Price Unit Source Method Rate
Apr 01, 2025 $484.20973 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Apr 01, 2025 $484.20973 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Apr 01, 2025 $484.20973 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Mar 19, 2025 $470.56339 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Feb 19, 2025 $470.62083 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 22, 2025 $470.62083 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 18, 2024 $470.62083 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 20, 2024 $470.62083 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 23, 2024 $470.62083 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Apr 17, 2024 $465.35689 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Apr 17, 2024 $465.35689 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jul 17, 2019 $394.13375 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 17, 2019 $394.13375 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026